Press releases | WebDisclosure

Basculer en Français

11293	Companies
250965	Keywords
179876	Articles
136835	Press releases

Home
Press releases

PRESS RELEASE

published on 04/13/2026 at 08:00, 6 months 24 days ago

Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer
Transgene completes patient randomization in Phase 2 of clinical trial for TG4050 in adjuvant treatment of head and neck cancer. Top-line results expected by Q1 2028

Clinical Trial Head And Neck Cancer Phase 2 Transgene TG4050
PRESS RELEASE

published on 04/13/2026 at 07:30, 6 months 24 days ago

PROJET DE CHANGEMENT DE CONTROLE DE LA SOCIETE INFOCLIP
Projet de changement de contrôle de la société Infoclip avec transfert des Managers-Cédants à la société RIVAGE GROUPE. Opération envisagée dans les prochaines semaines. Détails des modalités et conséquences

Transfert Opération Changement De Contrôle Infoclip RIVAGE GROUPE
PRESS RELEASE

published on 04/13/2026 at 07:00, 6 months 24 days ago

The Burkhalter Group exceeds expectations once again by posting excellent results for the 2025 financial year
Burkhalter Group exceeds expectations in 2025 with strong financial performance, proposing a dividend increase and targeting acquisitions. Focus on sustainability and positive outlook for 2026

Sustainability Financial Performance Acquisitions Dividend Increase Burkhalter Group
PRESS RELEASE

published on 04/13/2026 at 07:00, 6 months 24 days ago

Le Groupe Burkhalter surpasse une nouvelle fois les attentes et clôture l’exercice 2025 sur d’excellents résultats
Le Groupe Burkhalter dépasse les attentes avec d'excellents résultats financiers en 2025 et propose un dividende de CHF 5.20 par action. Acquisitions et engagement pour l'environnement renforcés

Dividende Résultat Annuel Environnement Burkhalter Holding AG Acquisitions Ciblées
PRESS RELEASE

published on 04/13/2026 at 07:00, 6 months 24 days ago

Swiss Re publishes its 2025 Financial Condition Report
Swiss Re publishes 2025 Financial Condition Report including SST analysis. Report available for download on Swiss Re's website. Important financial calendar dates announced

Financial Calendar Switzerland Swiss Re Financial Condition Report SST Analysis
PRESS RELEASE

published on 04/13/2026 at 07:00, 6 months 24 days ago

Twenty years of biosimilar medicines: a milestone that continues to transform patient access worldwide
Sandoz celebrates 20 years of biosimilar medicines with over USD 1.9 billion in savings for European healthcare systems. Biosimilars transform patient access worldwide

Sandoz Biologic Therapies Patient Access Biosimilar Medicines European Healthcare Savings
PRESS RELEASE

published on 04/13/2026 at 07:00, 6 months 24 days ago

Data published in Nature Communications highlights unique Mechanism of Action of Alpibectir in combination with Ethionamide (AlpE)
BioVersys AG and partners publish pre-clinical development data of AlpE in Nature Communications, showcasing unique Mechanism of Action targeting drug-resistance in tuberculosis

BioVersys AG Tuberculosis Nature Communications AlpE Drug-resistance
PRESS RELEASE

published on 04/13/2026 at 07:00, 6 months 24 days ago

ADS-TEC Energy reports preliminary and unaudited financial results
ADS-TEC Energy PLC reports preliminary and unaudited financial results for the year 2025, showing a strategic transition towards recurring revenue streams and diverse business models

Business Development Preliminary Results Battery Storage Solutions ADS-TEC Energy PLC Financial Overview
PRESS RELEASE

published on 04/13/2026 at 07:00, 6 months 24 days ago

DECLARATION DES TRANSACTIONS SUR ACTIONS PROPRES REALISEES DU 30 MARS AU 3 AVRIL 2026 DANS LE CADRE DU PROGRAMME DE RACHAT D'ACTIONS
Présentation agrégée par jour et par marché des transactions de l'émetteur Oeneo sur différents marchés avec volume et prix moyen

Développement Durable Transactions Marchés Financiers Chiffres Clés Oeneo
PRESS RELEASE

published on 04/13/2026 at 07:00, 6 months 24 days ago

Inside Information / Other news releases
Innate Pharma releases total shares and voting rights as of April 9, 2026, in compliance with French regulations. Learn about its innovative immunotherapies for cancer patients

Voting Rights Shares French Regulations Innate Pharma Immunothérapies

Accesswire

Published on 11/06/2026 at 22:15, 14 hours 56 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 1 day 3 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/06/2026 at 20:15, 16 hours 55 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 16 hours 55 minutes ago

L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 17 hours 55 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 18 hours 10 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 18 hours 38 minutes ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond

Les Echos

Published on 11/06/2026 at 19:06, 18 hours 4 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 18 hours 6 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 18 hours 9 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 18 hours 11 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 18:00, 19 hours 11 minutes ago

ICADE - CP - Notation crédit S&P

View all LES ECHOS COMFI WIRE